untillabs
untillabs (handle: @untillabs) publishes concise technical updates and social posts focused on reversible cryopreservation and organ-scale rewarming milestones. Coverage centers on technology signals rather than commercial timelines or tradable recommendations.
Past bets that played out
Highlights a technology milestone: Until Labs reported passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated at pig-kidney scale and described as having new “human organ-scale rewarming data.” The posts are a proof-of-concept signal referencing a likely private company and provide no commercialization timeline, regulatory pathway, or investable signals.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
What this channel is watching now
Recent mentions concentrate on cryopreservation and life-science instrumentation: CYRX, AZTA, Thermo Fisher Scientific (TMO), Danaher (DHR), and TMDX. The commentary emphasizes technical progress on reversible cryopreservation and rewarming rather than earnings, valuation, or market timing.
Latest videos and market context
No recent videos. Recent source content consists of social posts and blog updates describing reversible cryopreservation progress and event posts.
Until @untillabs Jun 9 Did you catch our latest blog post on our rewarming machine? 👀 With our magnet, a kidney can s...
Until Labs (@untillabs) promotes a blog post about a “rewarming machine” using a magnet to rapidly rewarm a kidney through the ice-formation “danger zone” in under a minute, drawing only a few kilowatts (usable from standard hospital outlets). This is product/technology marketing; no public-company financials, contracts, trials, regulatory status, or adoption signals are provided.
Pinned Until @untillabs Sep 22, 2025 We’ve raised $100M+ to date, we are developing reversible cryopreservation for p...
Until Labs claims it has raised $100M+ to develop reversible cryopreservation for donor-organ patients and is hiring. This is an early-stage private-company update with limited direct tradable implications; any public-market impact is indirect via themes in transplant/biopreservation and life-science tools.
We had such a lovely time meeting everyone last night at our screening of Anwar. Grateful to @FawazAM and @huntercole...
Social media post about a screening/Q&A for the film “Anwar.” No market, macro, sector, or company-specific information; no investable signal.
Until reposted Laura @LauraDeming · May 12 getting through the danger zone for ice formation in under a minute, with ...
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Proof-backed call history
Outputs are primarily social posts and blog updates. Recent items include a film screening/Q&A post, multiple posts about reversible cryopreservation and proprietary rewarming processes (including pig-kidney and human organ–scale rewarming data claims), and one link-only post with no analyzable content.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
About this channel
untillabs posts short-form updates from the Until Labs project, focusing on technical milestones in reversible cryopreservation and rewarming. Posts report experimental progress (e.g., passing the ice-formation danger zone quickly with low power at organ-relevant scale) but do not disclose company names, study protocols, partnerships, regulatory pathways, or commercialization timelines.
@untillabs
Most recognized assets
Unlock the full track record
Follow @untillabs for brief technical updates on cryopreservation milestones. These posts indicate technological progress but are not actionable investment recommendations.